stella
beta
Home
/
COVID-19
/
Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial
View on ClinicalTrials.gov
Completed
Back to COVID-19 trials
Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
United States
Brigham and Women's Hospital, Boston, Massachusetts
Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial — Stella